# Aizon

produces an AI-driven manufacturing-intelligence platform for pharma production combining analytics with compliance functions, with a documented strategic partnership (Sequence) extending AI-powered solutions across biopharmaceutical manufacturing.

Source: https://en.bioecon.ru/companies/aizon/
Updated: 2026-08-19

- Country: United States

## Verifiable facts

| Fact | Value | Source |
| --- | --- | --- |
| Funding | $44.1M total funding raised across 4 rounds | https://startupintros.com/orgs/aizon |
| Revenue | estimated between $12.6M and $25.1M annually [medium confidence] | https://getlatka.com/companies/aizon, https://healthydata.science/listings/aizon-how-top-pharma-leaders-are-using-ai-to-slash-time-to-market-by-30/ |
| Headcount | 131 to 159 employees | https://getlatka.com/companies/aizon |
| Certification | ISO 9001, ISO 27001, ISO 27017, and SOC 2 certifications | https://healthydata.science/listings/aizon-how-top-pharma-leaders-are-using-ai-to-slash-time-to-market-by-30/, https://www.aizon.ai/trust-center |
| Regulatory approval | Platform supports compliance with FDA 21 CFR Part 11 and EU GMP Annex 11, designed against GAMP 5 principles | https://www.aizon.ai/2025/for-llms, https://www.aizon.ai/trust-center |
| Production site | San Francisco, USA and Barcelona, Spain | https://startupintros.com/orgs/aizon, https://www.aizon.ai/2025/for-llms |
| Capacity | platform is scalable, supports from tens to more than 1,000+ batches per year [medium confidence] | https://connect.aizon.ai/hubfs/Aizon-GxP-AI-Pharma-Manufacturing-Data-Sheet.pdf, https://healthydata.science/listings/aizon-how-top-pharma-leaders-are-using-ai-to-slash-time-to-market-by-30/ |

Independent sources: getlatka.com, healthydata.science, startupintros.com

## Technologies

- [AI bioprocess optimization as SaaS](https://en.bioecon.ru/technology/ai-bioprocess-optimization-as-saas/)